Division of Kidney, Urologic & Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Division of Kidney, Urologic & Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Am J Kidney Dis. 2023 Jul;82(1):63-74.e1. doi: 10.1053/j.ajkd.2022.12.008. Epub 2023 Apr 27.
RATIONALE & OBJECTIVE: Acute kidney injury (AKI) carries high rates of morbidity and mortality. This study quantified various short- and long-term outcomes after hospitalization with AKI.
Retrospective propensity score (PS)-matched cohort study.
SETTING & PARTICIPANTS: Optum Clinformatics, a national claims database, was used to identify patients hospitalized with and without an AKI discharge diagnosis between January 2007 and September 2020.
Among patients with prior continuous enrollment for at least 2years without AKI hospitalization, 471,176 patients hospitalized with AKI were identified and PS-matched to 471,176 patients hospitalized without AKI.
OUTCOME(S): All-cause and selected-cause rehospitalizations and mortality 90 and 365 days after index hospitalization.
After PS matching, rehospitalization and death incidences were estimated using the cumulative incidence function method and compared using Gray's test. The association of AKI hospitalization with each outcome was tested using Cox models for all-cause mortality and, with mortality as competing risk, cause-specific hazard modeling for all-cause and selected-cause rehospitalization. Overall and stratified analyses were performed to evaluate for interaction between an AKI hospitalization and preexisting chronic kidney disease (CKD).
After PS matching, AKI was associated with higher rates of rehospitalization for any cause (hazard ratio [HR], 1.62; 95% CI, 1.60-1.65), end-stage renal disease (HR, 6.21; 95% CI, 1.04-36.92), heart failure (HR, 2.81; 95% CI, 2.66, 2.97), sepsis (HR, 2.62; 95% CI, 2.49-2.75), pneumonia (HR, 1.47; 95% CI, 1.37-1.57), myocardial infarction (HR, 1.48; 95% CI, 1.33-1.65), and volume depletion (HR, 1.64; 95% CI, 1.37-1.96) at 90 days after discharge compared with the group without AKI, with similar findings at 365 days. Mortality rate was higher in the group with AKI than in the group without AKI at 90 (HR, 2.66; 95% CI, 2.61-2.72) and 365 days (HR, 2.11; 95% CI, 2.08-2.14). The higher risk of outcomes persisted when participants were stratified by CKD status (P<0.01).
Causal associations between AKI and the reported outcomes cannot be inferred.
AKI during hospitalization in patients with and without CKD is associated with increased risk of 90- and 365-day all-cause/selected-cause rehospitalization and death.
急性肾损伤(AKI)具有较高的发病率和死亡率。本研究量化了 AKI 住院患者的各种短期和长期结局。
回顾性倾向评分(PS)匹配队列研究。
使用 Optum Clinformatics,一个全国性的索赔数据库,确定了 2007 年 1 月至 2020 年 9 月期间有和没有 AKI 出院诊断的住院患者。
在至少连续 2 年无 AKI 住院的患者中,有 471,176 例患者被确定为 AKI 住院,并与 471,176 例无 AKI 住院的患者进行了 PS 匹配。
指数住院后 90 天和 365 天的全因和特定原因再住院率和死亡率。
PS 匹配后,使用累积发病率函数法估计再住院率和死亡率,并使用 Gray 检验进行比较。使用 Cox 模型检验 AKI 住院与全因死亡率的关系,并在将死亡率作为竞争风险的情况下,使用特定原因危险建模检验全因和特定原因再住院的关系。进行了总体和分层分析,以评估 AKI 住院与预先存在的慢性肾脏病(CKD)之间的交互作用。
PS 匹配后,AKI 与任何原因的再住院率(危险比 [HR],1.62;95%置信区间,1.60-1.65)、终末期肾病(HR,6.21;95%置信区间,1.04-36.92)、心力衰竭(HR,2.81;95%置信区间,2.66-2.97)、败血症(HR,2.62;95%置信区间,2.49-2.75)、肺炎(HR,1.47;95%置信区间,1.37-1.57)、心肌梗死(HR,1.48;95%置信区间,1.33-1.65)和容量耗竭(HR,1.64;95%置信区间,1.37-1.96)的风险更高,而在 90 天时,AKI 组的死亡率(HR,2.66;95%置信区间,2.61-2.72)和 365 天时(HR,2.11;95%置信区间,2.08-2.14)也更高。当参与者按 CKD 状态分层时(P<0.01),这些结局的风险更高。
不能推断 AKI 与报告结局之间的因果关系。
CKD 患者和非 CKD 患者的 AKI 住院与 90 天和 365 天全因/特定原因再住院和死亡的风险增加有关。